GI
PRME icon

GAMMA Investing’s Prime Medicine PRME Stock Holding History

GAMMA Investing’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16K Sell
586
-61
-9% -$203 ﹤0.01% 3718
2026
Q1 		$2.25K Buy
647
+536
+483% +$2.04K ﹤0.01% 3637
2025
Q4 		$385 Buy
+111
New +$494 ﹤0.01% 3939
2024
Q4 		– Sell
-654
Closed -$2.53K – 3816
2024
Q3 		$2.53K Buy
654
+422
+182% +$1.96K ﹤0.01% 2990
2024
Q2 		$1.19K Buy
+232
New +$1.41K ﹤0.01% 3019
2024
Q1 		– Sell
-118
Closed -$749 – 3360
2023
Q4 		$749 Buy
+118
New +$909 ﹤0.01% 2874

Other funds holding PRME

MAM
Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return
APG
Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return
SWM
Shelton Wealth Management Fort Worth, Texas $255M AUM 34.47% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's PRME Position: Q2 2026 in Review

GAMMA Investing reduced its Prime Medicine (PRME) stake by 9.4% in Q2 2026, selling an estimated $203 and leaving 586 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #3718.

GAMMA Investing first reported a position in PRME in Q4 2023 and has held it in 6 quarters since. The position peaked at $2.53K in Q3 2024. 12 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • GAMMA Investing held 586 shares of Prime Medicine worth $2.16K as of Q2 2026.
  • GAMMA Investing sold 61 Prime Medicine shares in Q2 2026, an estimated $203.
  • Prime Medicine made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3718 holding.
  • GAMMA Investing first reported a position in Prime Medicine in Q4 2023 and has held it in 6 quarters since.
  • GAMMA Investing's Prime Medicine position peaked at $2.53K in Q3 2024.
  • 12 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.